The authors reveal that probenecid, an FDA-approved drug, uniquely modulates TRPV2 through an intracellular pocket. Probenecid drives the channel into an activated conformation, providing insights into potential therapeutic applications.
- Julia A. Rocereta
- Toni Sturhahn
- Vera Moiseenkova-Bell